KHK7580
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Secondary Hyperparathyroidism
Conditions
Secondary Hyperparathyroidism
Trial Timeline
May 1, 2014 → Dec 1, 2014
NCT ID
NCT02143271About KHK7580
KHK7580 is a phase 1 stage product being developed by Kyowa Kirin for Secondary Hyperparathyroidism. The current trial status is completed. This product is registered under clinical trial identifier NCT02143271. Target conditions include Secondary Hyperparathyroidism.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03280264 | Phase 3 | Completed |
| NCT02549417 | Phase 3 | Completed |
| NCT02549404 | Phase 3 | Completed |
| NCT02143271 | Phase 1 | Completed |
| NCT01935856 | Phase 1/2 | Completed |
Competing Products
20 competing products in Secondary Hyperparathyroidism